论文部分内容阅读
The title compound N-((2,6-difluorophenyl)carbamoyl)-1,3-dimethyl-1 H-pyrazole-4-carboxamide(C_(13)H_(12)F_2N_4O_2) was synthesized, and its structure was confirmed by ~1H NMR,HRMS and X-ray diffraction. It crystallizes in the monoclinic system, space group P2_(1/c) with a = 9.50(2), b = 10.11(2), c = 14.07(3) ?, β = 102.15(3)°, Dc = 1.480 g/cm~3, Z = 4, V = 1320(5) ?~3, the final R = 0.0789 and wR = 0.1860 for 1054 observed reflections with I > 2σ(I). The preliminary biological test shows that the title compound has weak antifungal activities.
The title compound N - ((2,6-difluorophenyl) carbamoyl) -1,3-dimethyl-1 H-pyrazole-4-carboxamide 1H NMR, HRMS and X-ray diffraction. It crystallizes in the monoclinic system with space group P2_ (1 / c) with a = 9.50 (2), b = 10.11 (2), c = 14.07 The final R = 0.0789 and wR = 0.1860 for 1054 with the reflections with I> 2σ (I) = 102.15 (3) °, Dc = 1.480 g / cm 3, Z = 4 and V = 1320 (5) The preliminary biological test shows that the title compound has weak antifungal activities.